Letter: Inflammatory Bowel Disease and Risk of Myocardial Infarction

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15644
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Letter: Phenotype and Natural History of Elderly Onset Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Gluten Sensitivity in Patients With Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Causes of Fatigue in Inflammatory Bowel Disease Remain Uncertain

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Letter: Risk Factors and Impacts of Psychological Morbidity in Young People With Inflammatory Bowel Disease - Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Letter: Faecal Calprotectin, Clinical Indices and the Diagnosis of Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Risk of Inflammatory Bowel Disease Following a Diagnosis of Irritable Bowel Syndrome

BMC Gastroenterology
MedicineGastroenterology
2012English

Inflammatory Gene Polymorphisms and Risk of Postoperative Myocardial Infarction After Cardiac Surgery

Circulation
Cardiovascular MedicinePhysiologyCardiology
2006English

Inflammatory Bowel Disease

Annual Review of Immunology
AllergyImmunology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy